This study investigates the expression, diagnostic significance, association with clinical characteristics and prognosis, genetic alterations, potential regulatory networks, correlation with immune infiltration and immune checkpoint genes, correlation with tumor mutational burden (TMB)/microsatellite instability (MSI), and drug sensitivity of ZNF692 across various cancer types. This evidence concerns the gene ZNF692 and neoplasm.